When does Michaelis-Menten (nonlinear) pharmacokinetics occur?

• A. When metabolic pathways saturate at high concentrations, causing clearance to decrease as concentration increases.
• B. When clearance increases with concentration.
• C. When drug binds to albumin.
• D. When renal clearance is zero.

Answer: (A)

Michaelis-Menten nonlinear PK happens when drug metabolism is saturable. When you have only a finite amount of metabolic enzyme, the rate of elimination cannot keep increasing as the drug concentration rises. At low concentrations, clearance is roughly constant and elimination behaves first-order. But at high concentrations, the enzymes become saturated and the rate of metabolism approaches a maximum (Vmax). In this regime, clearance declines as concentration increases because CL = Vmax/(Km + [S]). So adding more drug doesn’t speed up elimination, and you get disproportionately higher drug exposure.

That’s why the option describing saturation of metabolic pathways at high concentrations, with clearance decreasing as concentration increases, is the best answer. The other ideas don’t capture this saturable, concentration-dependent clearance: binding to albumin doesn’t by itself cause nonlinear clearance, a zero renal clearance scenario isn’t about saturation, and clearance increasing with concentration would imply a different PK behavior not described by Michaelis-Menten saturation.